p21-Activated Kinases, antagonists & inhibitors

Name
p21-Activated Kinases, antagonists & inhibitors
Accession Number
DBCAT003150
Description

Not Available

Drugs
DrugDrug Description
PF-03758309PF-03758309 has been used in trials studying the treatment of Advanced Solid Tumors.
Drugs & Drug Targets
DrugTargetType
PF-03758309Serine/threonine-protein kinase PAK 4target